What must an Investigator Site Audit Agenda include?

Include audit objectives, scope, schedule with times and locations, list of documents to review (with version dates), attendee roles, logistics, and reporting expectations. Accurate lists and dates reduce onsite delays and support traceability in the final audit report.

Who should approve and sign the agenda?

Typically the Principal Investigator or their designee approves the agenda; the audit lead or sponsor monitor may sign to acknowledge receipt. For institutional audits, department leadership or compliance officers may also sign to confirm resource availability.

Can the agenda be electronically signed?

Yes. Electronic signatures are valid under the ESIGN Act (15 U.S.C. ch. 96) and state UETA statutes when intent, consent, attribution, and record retention are present. For consumer-facing or PHI-containing records, ensure required disclosures and a BAA for HIPAA compliance.

Are witnesses or notarization required for the agenda?

Typically no for standard audit agendas. Notarization or witness requirements are document-specific and vary by state and document type. If an attached attestation or certification requires notarization or RON, follow state notary rules and retention for notary journals.

How long should I retain the audit agenda?

Retain the agenda for the duration of the study and post-termination per applicable rules: at least three years for tax/financial records (IRC §6501(a)), and six years for HIPAA-covered records (45 CFR §164.530(j)). Institutional policies may require longer.

How do I update or revise an agenda post-issuance?

Issue a revised agenda version with a clear version number and effective date. Circulate to all original recipients, note changes in a revision log, and preserve prior versions for audit traceability. Record approvals or acknowledgements per your document control procedures.

Electronic Signature
Templates
Miscellaneous
Investigator Site Audit Agenda

Investigator Site Audit Agenda

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

INVESTIGATOR SITE AUDIT AGENDA

RECITALS

WHEREAS, Client Name: engages Investigator/Organization: to conduct a site audit of the research site identified below; and

WHEREAS, the parties desire to set forth the agenda, scope, timing, responsibilities and administrative terms governing the on-site audit to confirm regulatory compliance, data integrity, and participant safety at Site Name: located at Site Address: .

WHEREAS, the audit will be conducted pursuant to the scope and schedule set forth below and the parties agree to cooperate to facilitate a timely, thorough, and documented review.

AUDIT OVERVIEW

Audit Date: — Expected Arrival Time: .

Primary Contact at Site: — Phone/Email: .

SCOPE OF WORK

The Auditor shall perform an on-site review limited to the items and procedures identified below and any follow-up activities reasonably necessary to document findings. The audit scope includes verification of regulatory documents, informed consent process, source data verification, investigational product handling, safety reporting practices, and overall compliance with the study protocol and applicable laws and regulations.

Detailed Scope (describe tasks, limits, and deliverables)

AUDIT AGENDA (PROPOSED)

1. Time: — Topic: — Lead:

2. Time: — Topic: — Lead:

3. Time: — Topic: — Lead:

Additional Agenda Notes

DOCUMENTATION TO BE REVIEWED

Please have the following documents available at the time of audit. Check items that will be provided and indicate responsible staff.

IRB/IEC approvals and correspondence — Responsible:

Signed informed consent forms — Responsible:

Source documents and case report forms — Responsible:

PAYMENT TERMS

The Client agrees to compensate the Investigator for on-site audit services as follows. The Investigator shall submit an invoice referencing this agenda and the audit date.

Audit Fee (USD) Payment Schedule and Terms Late Fee Billing Address

TERM AND TERMINATION

Effective Date: — Completion Date (if applicable): .

Notice Period for Termination Termination for Cause (describe)

CONFIDENTIALITY

All information reviewed or collected in the course of the audit, including but not limited to source documents, regulatory files, and identifiable participant information, shall be treated as confidential. The Auditor shall use such information solely for purposes of the audit and shall not disclose confidential information except as required by law. The Auditor shall implement appropriate measures to protect confidential data and return or destroy copies as requested by the Site or Sponsor.

By checking this box and signing below, the parties acknowledge and accept the confidentiality obligations set forth in this Agenda and Agreement.

GOVERNING LAW

This Agenda and Agreement shall be governed by and construed in accordance with the laws of State: without regard to principles of conflicts of law.

ENTIRE AGREEMENT

This document, together with any attachments and referenced schedules executed by the parties, constitutes the entire agreement between the parties with respect to the subject matter herein and supersedes all prior and contemporaneous agreements, understandings and representations. Any amendment must be in writing and executed by authorized representatives of both parties.

AUDITOR CERTIFICATION

The undersigned Auditor certifies that the audit will be performed in accordance with professional standards, that findings and observations will be reported accurately and objectively, and that any conflicts of interest impacting impartiality have been disclosed in writing to the Site or Sponsor prior to the audit.

Conflict Disclosure (if applicable):

Site Representative:

By:

Date:

Auditor / Investigator:

By:

Date:

What an Investigator Site Audit Agenda Is

An Investigator Site Audit Agenda is a written schedule and roadmap used to plan and conduct audits at a clinical trial site. It identifies audit objectives, scope, locations to inspect, documents to review (regulatory binder, informed consent forms, source data, drug accountability), required attendees, and time allotments for each activity. The agenda helps the audit team, site staff, sponsor monitors, and regulatory representatives coordinate logistics, prepare materials, and ensure efficient use of on-site time. A clear agenda reduces omissions, supports compliance, and provides a documented basis for the audit report and follow-up actions.

Why an Investigator Site Audit Agenda Matters

A concise Investigator Site Audit Agenda aligns expectations, focuses review on regulatory and protocol priorities, reduces unnecessary on-site time, and documents planned scope. It improves audit traceability and supports timely corrective actions when deficiencies are identified.

Who typically uses this agenda

Clinical research teams, sponsor monitors, and independent auditors use the Investigator Site Audit Agenda to coordinate onsite reviews and document expectations.

Principal investigator and study staff coordinating responses, providing source data, and answering auditor questions.
Sponsor or CRO monitors organizing agenda, overseeing scope, and verifying regulatory adherence.
Independent quality assurance or regulatory inspectors assessing compliance and documentation completeness.

The agenda also guides IRB liaisons, safety officers, and vendors when their input is required.

Step-by-step: Prepare the Investigator Site Audit Agenda

Follow these steps to prepare a complete, compliant Investigator Site Audit Agenda that aligns reviewers, schedules, and required documents.

01

Assign Lead: Name the audit lead and contact details.
02

Define Scope: List protocol sections, systems, and processes to review.
03

Schedule: Set date, times, and time allotments per activity.
04

Attach Documents: Enumerate documents to bring or upload before the audit.

Core sections every Investigator Site Audit Agenda should include

A professional Investigator Site Audit Agenda organizes objectives, timing, attendees, documents, logistics, and reporting expectations so audits proceed systematically and results are reproducible.

Audit objectives

Define specific compliance areas, protocol adherence points, and safety monitoring items to examine. Clear objectives prioritize document retrieval and focus interview topics for site staff and monitors.

Agenda timeline

Provide a minute-by-minute or hourly schedule with locations and allocated reviewers. Include buffer time for discussions, evidence collection, expected document handoffs, and unexpected follow-up requests.

Required documents

List regulatory binder sections, current IRB approvals, informed consent forms, source data, drug accountability logs, monitoring letters, and SAE reports with version dates for retrieval.

Attendees and roles

Name expected attendees (investigator, coordinator, monitor, QA, pharmacist) and specify responsibilities during interviews, document provision, corrective action planning, and point of contact for logistics and follow-up.

Logistics

State on-site room, parking instructions, security requirements, data access arrangements, Wi‑Fi credentials if needed, contact phone numbers for day-of coordination, and backup plans for document transmission.

Reporting and follow-up

Describe reporting format, expected timelines for draft and final reports, responsibility for corrective action, and how findings will be tracked until closure, including evidence of remediation and verification steps.

Configure an online workflow for agenda distribution

Configure digital workflows so the agenda, attachments, and sign-offs are distributed, authenticated, and archived with clear version control.

Field	Configuration
File format	PDF preferred; DOCX accepted; preserve layout.
Authentication	Email link, SMS code, or KBA per sensitivity.
Fields	Signature, initials, date, and conditional checklists.
Notifications	Email confirmations and audit trail delivery to stakeholders.

Platform and format requirements for eSubmission

Use platforms that accept PDF/DOCX, preserve metadata, support audit trails, and allow secure sharing with role-based access.

Supported formats: PDF, DOCX, and Excel.
Integrations: Salesforce, NetSuite, Microsoft 365, Google Workspace.
Security: TLS 1.2/1.3 and AES-256 at rest.

Where to send and file the completed agenda

Define routing for the finalized agenda so that sponsors, IRBs, and institutional archives receive the correct version and supporting evidence without delay.

Sponsor portal: Upload final agenda to sponsor or CRO system.
IRB submission: Send required documents to the IRB or ethics committee.
Trial master file: Archive agenda and attachments in the TMF.
QA notification: Notify quality assurance and compliance teams.

Important deadlines to set in the agenda process

Set clear deadlines for agenda draft, distribution, on-site audit, report delivery, and corrective action to maintain compliance and oversight.

Draft agenda submission deadline recommended:

At least 14 days before the audit date.

Agenda distribution to stakeholders and reviewers:

No later than 7 days before audit.

On-site audit date and time:

As scheduled; ensure staff availability and escorts.

Draft report issuance timeline target:

Initial draft within 30 calendar days post-audit.

Corrective action response due date:

Typically within 60 days unless extended by agreement.

Milestones: from planning to close-out

Use a milestone sequence to track planning, execution, reporting, and closure of the Investigator Site Audit Agenda lifecycle.

01

Planning

Scope defined, lead assigned, documents requested ahead.

02

Pre-audit review

Site compiles documents and responds to queries.

03

On-site execution

Interviews, document review, and sampling performed.

04

Close-out

Draft findings, corrective plan, and follow-up timeline.

How an Investigator Site Audit Agenda differs from routine monitoring visits

Compare Investigator Site Audit Agenda to related visit agendas to clarify purpose, depth, and deliverables for stakeholders and reviewers.

Criteria	Investigator Site Audit Agenda	Monitoring Visit Agenda
Purpose	in-depth compliance review	routine monitoring checks
Typical depth	comprehensive	targeted
Required attendees	audit team, qa, sponsor	pi, coordinator, monitor
Output	formal report with capa	monitoring note or memo

Real-world examples of Investigator Site Audit Agendas

These examples show how agendas look for common audit types across sponsors and site-initiated reviews.

Sponsor audit

A mid-sized sponsor scheduled a two-day Investigator Site Audit Agenda focusing on informed consent procedures, SAE reporting, and data reconciliations across five enrolled subjects.

Team required source documents and pharmacy logs.
The agenda allocated targeted review blocks, reduced document turnaround time by focusing document retrieval, and produced a draft report within ten business days that identified two minor corrective actions with assigned owners and deadlines.

Site-initiated QA audit

A single-site investigator performed an internal audit using a one-day Agenda emphasizing source data verification, protocol deviation logs, and staff training records.

Focus on corrective action tracking and staff interviews.
Following the agenda, the investigator issued a corrective action plan, updated training logs, and archived documentation in the trial master file; subsequent monitoring visit confirmed remediation within the prescribed timeframe.

Types of sensitive information included in agendas and attachments

Protected health information: Includes consent forms and source data.

Regulatory binder: Essential trial documentation and approvals.

Source documents: Patient charts and case report data.

Drug accountability records: Drug logs, receipts, and dispensing records.

Personnel credentials: CVs, licenses, and training records.

Audit trail records: Timestamps, access logs, and changes.

Penalties and risks from poor agenda preparation

Regulatory findings: May lead to warning letters.

Data integrity risk: Compromised study validity.

HIPAA breach exposure: Potential civil penalties.

Study suspension: Recruitment or activity pauses.

Legal liability: Contractual breach claims.

Financial penalties: Fines and remediation costs.

Common mistakes to avoid when preparing the agenda

Incomplete documentation: missing signatures, undated forms, or incomplete source-to-CRF reconciliation increases reviewer time and may result in formal findings.
Poor scheduling: last-minute agendas or conflicting time slots prevent key staff attendance and reduce opportunity for clarification during audit meetings.
Vague scope: unspecified protocol sections or omitted systems cause scope creep, uncoordinated document searches, and incomplete audit coverage.
Weak authentication: failure to confirm signer identity or to record consent for electronic signatures undermines legal enforceability.

eSignature vendor comparison for signing and distributing the agenda

Pricing and feature comparison for common eSignature vendors to support eSigning and secure distribution of Investigator Site Audit Agenda records.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Yes	Yes	Yes	Yes
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No cap	100 envelopes/user/year	Varies by plan	Varies by plan	Varies by plan

FAQs: Investigator Site Audit Agenda

Answers to common questions about preparing, signing, submitting, and retaining the Investigator Site Audit Agenda in clinical research settings.

Need help? Contact support

What must an Investigator Site Audit Agenda include?
Include audit objectives, scope, schedule with times and locations, list of documents to review (with version dates), attendee roles, logistics, and reporting expectations. Accurate lists and dates reduce onsite delays and support traceability in the final audit report.
Who should approve and sign the agenda?
Typically the Principal Investigator or their designee approves the agenda; the audit lead or sponsor monitor may sign to acknowledge receipt. For institutional audits, department leadership or compliance officers may also sign to confirm resource availability.
Can the agenda be electronically signed?
Yes. Electronic signatures are valid under the ESIGN Act (15 U.S.C. ch. 96) and state UETA statutes when intent, consent, attribution, and record retention are present. For consumer-facing or PHI-containing records, ensure required disclosures and a BAA for HIPAA compliance.
Are witnesses or notarization required for the agenda?
Typically no for standard audit agendas. Notarization or witness requirements are document-specific and vary by state and document type. If an attached attestation or certification requires notarization or RON, follow state notary rules and retention for notary journals.
How long should I retain the audit agenda?
Retain the agenda for the duration of the study and post-termination per applicable rules: at least three years for tax/financial records (IRC §6501(a)), and six years for HIPAA-covered records (45 CFR §164.530(j)). Institutional policies may require longer.
How do I update or revise an agenda post-issuance?
Issue a revised agenda version with a clear version number and effective date. Circulate to all original recipients, note changes in a revision log, and preserve prior versions for audit traceability. Record approvals or acknowledgements per your document control procedures.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now